News & events

PIONEER: The International Network of Excellence for Big Data in Prostate Cancer announces that consortium partner SAS has deployed their latest advanced analytics capabilities in the central PIONEER Big Data Platform for Prostate Cancer. In partnership with the Center...

Multiple diagnostic & prognostic biomarkers are available to improve prostate cancer diagnosis and prognosis. However, knowledge on which diagnostic and prognostic biomarkers can be used to select patients for a specific treatment remains unclear. Developed by a multidisciplinary team...

PIONEER: The International Network of Excellence for Big Data in Prostate Cancer announces the release of their core outcome sets for localised, locally advanced, metastatic and non-metastatic castration resistant prostate cancer. The PIONEER Core Outcome Sets (COS) for Localised,...

Prostate Cancer (PCa) is characterised by a relatively long natural history, where a substantial proportion of PCa patients die from causes other than the disease itself. As a result of this there is an increasing awareness of the importance...

Data science specialist CASUS and the PIONEER research consortium ally in the fight against prostate cancer The Centre for Advanced Systems Understanding (CASUS) at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has joined PIONEER, a € 12.8m euro project funded by the...

Coordinated by PIONEER the five Big Data 4 Better Outcomes (BD4BO) projects of the Innovative Medicines Initiative have come together in light of their experience to make recommendations to inform EU decision makers in order to respond to the...